Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P00790 (
PGA
)
2,475
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Recent study has shown that biodegradable polymers are attractive candidates for chondrocyte fixation and further transplantation in cartilage tissue engineering. Poly (glycolic acid) (
PGA
), a polymer of glycolic acid, is widely used in orthopedic applications as a biodegradable polymer. Organotin, lead, antimony, and zinc are catalysts commonly used in synthesizing
PGA
. Here, we investigated the biocompatibility of
PGA
, synthesized with and without inorganic
tin
as a catalyst in chondrogenesis of human articular chondrocytes in a micromass culture system. Significant enhancement of chondrocyte proliferation and expression of the collagen type II protein gene were observed in cultures treated with
PGA
synthesized with a
tin
catalyst. However, aggrecan gene expression was very similar to the control culture. Amount of collagen type II protein was also increased in the same group of cultured chondrocytes. In contrast,
PGA
without a catalyst caused overall inhibition of chondrogenesis. Despite several positive findings, extensive investigations are essential for the feasibility of this
PGA
(Sn) in future clinical practice.
...
PMID:Effects of a biodegradable polymer synthesized with inorganic tin on the chondrogenesis of human articular chondrocytes. 1635 12
Due to the low solubility of poly(glycolic acid) (
PGA
), its use is generally limited to the synthesis of random copolyesters with other hydroxy acids, such as lactic acid, or to applications that permit direct processing from the polymer melt. Insolubility is generally observed for
PGA
when the degree of polymerization exceeds 20. Here we present a strategy that allows the preparation of
PGA
-based multi-arm structures which significantly exceed the molecular weight of processable oligomeric linear
PGA
(<1000 g/mol). This was achieved by the use of a multifunctional hyperbranched polyglycerol (PG) macroinitiator and the
tin
(II)-2-ethylhexanoate catalyzed ring-opening polymerization of glycolide in the melt. With this strategy it is possible to combine high molecular weight with good molecular weight control (up to 16,000 g/mol, PDI = 1.4-1.7), resulting in
PGA
multi-arm star block copolymers containing more than 90 wt % GA. The successful linkage of
PGA
arms and PG core via this core first/grafting from strategy was confirmed by detailed NMR and SEC characterization. Various PG/glycolide ratios were employed to vary the length of the
PGA
arms. Besides fluorinated solvents, the materials were soluble in DMF and DMSO up to an average arm length of 12 glycolic acid units. Reduction in the T(g) and the melting temperature compared to the homopolymer
PGA
should lead to simplified processing conditions. The findings contribute to broadening the range of biomedical applications of
PGA
.
...
PMID:Poly(glycolide) multi-arm star polymers: Improved solubility via limited arm length. 2070 81